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Abstract
The retinal pigment epithelium is an important part of the vertebrate eye, particularly in studying the causes and possible
treatment of age-related macular degeneration. The retinal pigment epithelium is difficult to access in vivo due to its
location at the back of the eye, making experimentation with age-related macular degeneration treatments problematic.
An alternative to in vivo experimentation is cultivating the retinal pigment epithelium in vitro, a practice that has been
going on since the 1970s, providing a wide range of retinal pigment epithelial culture protocols, each producing cells
and tissue of varying degrees of similarity to natural retinal pigment epithelium. The purpose of this review is to provide
researchers with a ready list of retinal pigment epithelial protocols, their effects on cultured tissue, and their specific
possible applications. Protocols using human and animal retinal pigment epithelium cells, derived from tissue or cell lines,
are discussed, and recommendations for future researchers included.
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Introduction
The retinal pigment epithelium (RPE) is a layer of tissue
found in the vertebrate eye between Bruch’s membrane
and the photoreceptor layer of the neural retina.1 It is
derived from the outer layer of the optic cup,2 possesses
an innate immune system,3 and consists of a monolayer of
highly pigmented cells that fit together in a tight matrix
(Figure 1).5–7 The monolayer is often compared to a
mosaic or cobblestones in its configuration, while the
shape of the individual cells is usually described as polygonal/hexagonal, columnar (aligned perpendicular to the
underlying membrane), or “epithelioid.” The cells are
strongly polarized,8 with microvilli on the apical surface.9
Despite its simplicity as a tissue layer, the RPE plays
many complex roles in the vertebrate eye, including regulation of retina development,10,11 absorption of excess
light entering the eye to reduce photo-oxidative stress,12
secretion of growth factors such as vascular endothelial
growth factor (VEGF),5,11,13 mediation of the immune
response of the eye,14–16 transportation of metabolites and
fluids,17–19 and phagocytosis of spent rod and cone outer

segments.20–27 The RPE also acts as an intermediate for
supplying glucose and other vital nutrients to the retina28
while maintaining a healthy environment for the photoreceptors29 and preventing large molecules from entering
the eye from the bloodstream.30 This last purpose designates the RPE as part of the blood–retinal barrier, which is
primarily in place to stop particles from entering the vitreous humor and obscuring vision.31–33 While the RPE plays
many roles in the eye, its greatest medical significance
comes from its involvement in many ocular disorders34
that can lead to vision loss or blindness, such as retinitis
pigmentosa, diabetic retinopathy, West Nile virus, and
macular degeneration.4,13,35–46
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Figure 1. Diagram of the outer retina, showing the retinal pigment epithelium and its location between Bruch’s membrane and the
neural retina. Pigment granules, tight junctions, and monolayer formation are indicative of natural-type RPE cells.4

Macular degeneration in particular is currently of
great interest to medical and biological researchers. Agerelated macular degeneration (AMD) is a disorder of the
retina characterized by loss of sight in the center of the
visual field and is the leading cause of vision loss after
age 50 years in developed.47 AMD occurs in two forms:
the exudative or “wet” form and the nonexudative or
“dry” form. Wet AMD (the most severe form, also called
choroidal neovascularization) is caused by excessive
growth of capillaries from the choroid into Bruch’s
membrane and the RPE, in correlation with production of
VEGF (a soluble factor produced by the RPE).48–50 These
fragile new blood vessels exude blood, lipid, and protein
below the macula (the central region of the retina, necessary for visual acuity), causing scarring and sudden acute
vision loss.51 Dry AMD (the most common type, also
called atrophic AMD or geographic atrophy)52 is a much
slower process, characterized by degeneration of the RPE
and later the neural retina,51,53,54 which can lead in some
cases to tearing of the RPE.55 Its causes are not fully
understood,56–58 although evidence suggests contributing
factors include the accumulation of lipofuscin and other
substances in the eye,33,59–64 disruption of autophagy and
other processes in the RPE,24,27,65–67 photo-oxidative
stress caused by excess light entering the eye,33,63,68–74
genetic factors,36,51 and other retinal disorders like focal
choroidal excavation (FCE).75
Both AMD types are characterized by the presence
of lipid-based deposits, or soft drusen between the RPE

and Bruch’s membrane,76–79 as well as hypo- and
hyperpigmentation of the RPE itself.51,80 Other factors
involved in AMD, such as iron accumulation, oxidative
stress and lipofuscin accumulation,33,51,58,81–83 and VEGF
production,84,85 are processes in which the RPE is
directly involved. This suggests that the RPE plays an
essential part in AMD progression and perhaps inception. Whether the RPE is directly or indirectly involved
with AMD development, evidence suggests that research
and experimentation with this particular tissue layer
are necessary for learning more about this crippling
disease.86–89
While AMD research has been conducted for many
years, there is still no available chemical or surgical
treatment for reversal of vision loss in the dry form of
the disease.48,54,90,91 Many researchers are exploring
possibilities for treatment, such as slowing deterioration in the intermediate stage through high doses of
vitamin supplements such as lutein and zeaxanthin,92
treatments like laser photocoagulation,47 use of stem
cells to replace degraded cells,93–97 and even gene
therapy.70,98 However, because RPE cells are largely
non-proliferative throughout life, regeneration and
repair of the already-damaged tissue is normally impossible.35 While necessary for visual function, the blood–
retinal barrier also makes chemical experimentation
with AMD treatment unproductive, because it inhibits
drug treatments from passing from the blood to the vitreous humor.99 This, as well as its location at the back of
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the eye, makes observation of and experimentation
with the RPE difficult in vivo.49
One possible alternative to in vivo RPE research is to
culture RPE cells in vitro.100–102 RPE cell culture has been
practiced for over 40 years at the time of this writing103 and
over the decades many methods for producing viable RPE
cells have been demonstrated. While RPE cells are normally non-proliferative in adults, they can be induced to
re-enter their glycolytic metabolism stage in which proliferation, migration, and differentiation is possible, allowing
them to re-establish a viable monolayer in medium.104–106
Cultured RPE cells can be used in a variety of applications,
many of which are applicable to AMD research.29 One
application, as intimated above, is the use of cultured RPE
cells as a testing ground for AMD drug treatments. A
researcher searching for a possible cure for AMD could
induce atrophy in the RPE monolayer before introducing
various chemicals or supplements to observe their effect
on the cultured cells. Such an experimenter would most
likely desire an RPE culture in which the orientation, configuration, and morphology of the cells were similar to
those found in the natural RPE. The culture would fulfill
its function most effectively if it produced a dense monolayer of epithelioid cells with dark pigmentation and tight
intercellular junctions, similar to the in vivo characteristics
of RPE.107 However, despite the amount of time and energy
that has been spent on improving RPE culturing techniques, difficulties still arise as scientists attempt to produce a pigmented, epithelioid monolayer that best mimics
native RPE tissue.
RPE cells may exhibit considerable phenotypic variation depending on their growth conditions.108 Some of the
most common problems are loss of pigmentation in the
cultured cells, low cell–substrate adhesion rates, alterations in cell morphology (in particular, a tendency for
epithelioid cells to transform into long, fibroblast-like,
“fusiform” cells,20,52,105 a natural process that occurs in
the eye when the RPE is damaged to produce cells capable of propagating),20,103 and low yield of viable cells
from those harvested.109 Many of these problems can be
attributed to variations in cell seeding density, freshness
(for cells grown from living tissue), culture medium
composition, incubation conditions, passage number,52
and substrate topography,110 and any researcher attempting to closely replicate native RPE tissue in vitro would
be well advised to search published protocols for the
right procedure.
One of the most common methods of measuring RPE
confluence and cell density is transepithelial resistance
(TER). TER is used to measure the ion flow across
the epithelial layer, increasing with time as a culture
develops7,50 with a higher TER indicating higher confluence, strong polarization of the RPE monolayer, and tight
junctions between cells,7 all properties that are important
to the RPE’s function as a barrier.111 Typical TER for the
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living human RPE is 150 Ω cm2, while cultured RPE
34
monolayers have been measured as low as 25 Ω cm2 and
as high as 500 Ω cm2.7 A full range of typical TER values
for RPE monolayers in different species both in vitro and
in situ can be found in Rizzolo.32 TER values should be
viewed by the RPE researcher as an accurate measure of
the cultured monolayer’s similarity to natural RPE, and as
the monolayer’s effectiveness as a barrier.
Another application for RPE culture is the cultivation
of cells intended for direct RPE transplant, a line of
research already being explored by several groups.90,112–115
RPE transplantation experiments have been performed
using in vivo harvested cells from the same patient,116,117
and research oriented toward growing layers of healthy
RPE tissue that can be transplanted into the eyes of patients
suffering from AMD to replace any damaged or atrophied
cells is a growing field.118 While this course of action may
be effective in curing AMD, at least temporarily, it would
also require donor/transplant compatibility, invasive ocular surgery, a substrate that can be transplanted with the
cells (since experiments using RPE cell suspensions and
loose sheets injected directly into the eye have been largely
unsuccessful),90,119 and an even higher standard of monolayer fidelity and morphological similarity to the human
eye than a culture grown for experimentation. Nevertheless,
many researchers47,90,120 see RPE transplant as a viable
method for treating AMD and have developed culture protocols accordingly.
One phenomenon that has been observed by RPE
researchers is the tendency for cultured RPE cells to spontaneously transform into cell lines.121 RPE cell lines are
often characterized by extended cell life, changes in cell
morphology, and sometimes immortality. While this makes
them useful for extended experimentation, it renders them
unsuitable for transplantation, and in addition may not
produce accurate results in a drug treatment study. Culture
protocols that give rise to cell lines, therefore, are best
suited for RPE research that allows for morphological differences between the culture and natural RPE.
Another cell transformation phenomenon that has been
reported in RPE cell cultures is the activation of ordinary
RPE cells into stem cells.35,122–124 The RPE begins life as a
plastic tissue that is capable of producing lens and retina in
some species, but quickly loses this competency as it differentiates into largely non-proliferative RPE cells.125,126
However, either by active induction or spontaneously,
RPE cells in culture have shown the ability to transform
into self-renewing multipotent cells that can give rise
to optical, neural, and mesenchymal tissue under certain
conditions.35,127 This opens up another avenue of AMD
research: producing new RPE cells and perhaps neural
retina tissue from retinal pigment epithelial stem cells
(RPESCs) to replace those damaged by the disease. Under
ordinary circumstances, human RPE cells do not replace
themselves when damaged, unlike in some other species,
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where injury to the eye can result in the RPE not only
regenerating itself but also the neural retina.35,128 The
transformation of RPE cells into stem cells is often marked
by the appearance of spheroid colonies that detach
from the substrate and float, and cells re-cultured from
floating colonies have shown self-renewing properties.123
Activation of these latent plastic properties may aid in
recovery of AMD patients without the need for entire RPE
sheet transplants.
With these four applications (drug experimentation,
transplants, cell line generation, and stem cell generation),
there is ample opportunity for RPE cell cultures to be used
in AMD research. However, not every cell culture method
will be right for every application. For example, since selfdifferentiating multipotent RPE cells are suspected to be
the source of mesenchymal cell fates in disorders such as
proliferative vitreoretinopathy (PVR),123 a cell culture that
is conducive to the spontaneous production of stem cells
may not be suitable for transplants. The same way, a transformed cell line may be useful for some experimentation,
but the morphological and growth changes that accompany transformation may make the cells too different from
natural RPE to be used in drug treatment tests or transplants. For this reason, a researcher must be careful to
select a culturing protocol that will best suit the needs of
their project.
The purpose of this literature review is to examine the
various protocols that have been developed and used since
the earliest days of RPE culture and to compare different
methods (including cell source and harvesting procedure,
culture medium and substrate, incubation conditions, and
passage method) so that researchers attempting to culture
RPE cells can have a ready reference to aid in selecting the
protocol that is best for one of the four purposes listed
above. Research into culturing RPE tissue is divided into
two main branches, based on cell sources: cultures grown
from harvested tissue and those grown from established
cell lines (while the generation of RPE cells from stem
cells is a third possibility,94,118,129,130 this review will focus
on the previous two methods). This review will first examine cultures using donor organisms as a cell source, then
the culturing procedures of cell lines.

Cells obtained from tissue
Before the establishment of cell lines, the only possible
source for researchers trying to culture RPE cells was from
the tissue of living and recently deceased vertebrates.
When cultivating such cells, the basic procedure is to first
harvest the cells from the tissue, usually with the help of a
digestive enzyme to degrade the structural proteins holding the cells in place. Often this requires removal of the
eye from the surrounding tissue (enucleation) and dissection of the eye globe, most commonly by cutting off the
anterior portion of the eyeball (see Figure 2) and leaving
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Figure 2. Schematic of the vertebrate eye, with vertical
dashed line to illustrate where incision is usually made when
creating an “eyecup” from which RPE cells are harvested.35

Figure 3. Dissected human fetal eyecup, with neural retina
removed and RPE cells visible as dark layer on quartered
tissue.4

an “eyecup,” with the RPE coating the interior (shown in
Figure 3, quartered), into which digestive enzymes (such
as trypsin and dispase, two of the most common proteins
used) can be poured.131 An alternative (sometimes used in
conjunction with enzymatic digestion) is to remove the
RPE from the eye through mechanical means, such as with
forceps or dissection blades, often in a single sheet or fragments of a sheet. This can often lead to contamination
from choroidal cells, but is beneficial in that it may maintain the epithelial mosaic-like structure of the RPE. After
cell harvesting, the next step is usually to transfer the cells
into a culture medium and allow them to adhere to a
substrate that is conducive to the growth of a cellular
monolayer. Incubation follows, usually at a set of standard
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conditions common to mammalian cell cultures (~37°C,
5% CO2). If the cells are allowed to grow to confluence,
they are usually passaged, again using a mild digestive
enzyme to dissolve them from the substrate, with a certain
number of passages possible before cell senescence and
death.
Generally, the benefit of using tissue as a cell source is
that the cells are already in the native mosaic configuration,
encouraging the cells to continue to grow in a single monolayer that best matches the natural structure of the RPE.
However, as cells are often dissolved from their configuration and re-suspended in culture medium, a greater advantage is that the cells may maintain their morphology and
pigmentation, which are often lost when using transformed
cells from cell lines. In the following sections, established
protocols for cultivating cells obtained from humans
(living, dead, adult, and fetal) will be examined, followed
by cultures of cells taken from nonhuman vertebrates.

Human cell sources
The human RPE is, of course, the best model for testing
treatments for human ailments, and is also the acceptable
source for human RPE transplants, cell lines, and stem
cells. Culturing of human RPE has been going on since the
1970s,103 and many of the practices developed then are still
in use today, particularly the method for harvesting cells
from the human eye. In the early days, Mannagh et al.132
cultured RPE cells in an experiment simply to discover the
suitability of human RPE for laboratory culture, and used
a cell-harvesting method still commonly practiced today
by RPE researchers. The adult human RPE cells were
extracted from eyes harvested for corneal transplants that
had either been found unsuitable for transplantation or had
already had the cornea removed. The eyes were first dissected by removing the anterior half of the globe 6 mm
behind the limbus (for rough diagram see Figure 2) and the
resulting posterior eyecup inverted, removing the vitreous
body and retina. The RPE was then digested enzymatically, using 0.03% Pronase (a commercial mixture of proteases derived from Streptomyces griseus) in a calcium
and magnesium-free balanced salt solution. The cup was
filled with about 5 mL of the Pronase solution and incubated at 37°C for 20–30 min, freeing the RPE cells from
Bruch’s membrane. The cells were then harvested by
repeated aspiration of the Pronase solution through an
18-gauge needle on a 5-mL syringe, and the resulting suspension centrifuged in a 5-mL conical tube at 1000 r/min
for 3 min. After centrifuging, the supernatant solution was
pipetted off and the cell pellet re-suspended in 1 mL of
Eagle’s minimum essential medium (EMEM), 15% supplemented with fetal bovine serum (FBS),* and the new
suspension placed in a Rose chamber or T-15 flask filled
with the same medium. Interestingly, in the case of eight
pairs of eyes used as cell sources, only one eye in each pair
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gave rise to a viable culture. Mannagh et al. noted a negative relationship between the age of the donor and the viability of the culture, with 75% success (57 out of 76
cultures) for donors under 60 years but only 58% (62 of
106 cultures) for donors over 60 years.
The viable cultures were found to form small adherent
clusters of round, heavily pigmented cells on the floor of
the container 48 h after inoculation, when mitotic activity
was also detected. After cells were observed, the medium
was changed to remove the free-floating pigment granules
that had escaped into the solution. Mitosis continued for
about 30 days (with the medium being changed twice each
week), after which a confluent monolayer would completely form on the floor of a Rose chamber. Confluent
cultures were passaged using 0.25% trypsin in calcium
and magnesium-free balanced salt solution at 37°C.
Pigmentation loss was noted with each cell division, and
attempts to stimulate pigment formation by the addition of
adrenocorticotrophic hormone (ACTH, 0.5 U/mL) were
unsuccessful. The researchers observed spontaneous transformation of primary cultures into cell lines in 7 cases,
all of which resulted in a change in cell morphology to
a smaller, more uniform shape and accelerated growth.
These cell lines were successfully passaged and seeded at 1
× 105 cells/mL. The effectiveness of Pronase as a means of
separating the RPE cells from Bruch’s membrane was demonstrated by fixing the posterior eyecup in formalin, removing the choroidal tissue and flattening it by radial incision,
dehydrating it in alcohol, clearing it with xylene, and
mounting it lamina-vitrea-up on a glass slide. The mounted
tissue was examined using light and phase microscopy and
found to consist of denuded Bruch’s membrane, with only
RPE cells removed by the process. This protocol demonstrated the culturing potential of RPE cells and their ability
to spontaneously produce cell lines, and while somewhat
less-refined than later protocols is still effective for a
researcher merely wishing to culture RPE cells for practice
or for the purpose of cell line production.
Around the same time, Tso et al.133 cultured RPE cells
to discover the extent of morphological changes experienced by RPE cells upon removal from Bruch’s membrane. The cells were obtained from both cadavers and
from living patients whose eyeballs were enucleated for
melanoma and retinoblastoma. The eyes were opened in
culture medium RPMI 1640 (Roswell Park Memorial
Institute medium; Grand Island Biological Co., Grand
Island, NY, USA), with the RPE and uvea separated
together from the sclera, placed on a Millipore filter
(EMD Millipore, Billerica, MA, USA) choroid-down, and
kept within the medium for the remainder of the procedure. The cultures were placed in Leighton tubes filled
with 2 mL of the same medium and incubated at 37°C,
with medium changes twice a week. For the first 3 days,
the cells retained epithelial properties and pigmentation,
with some less-pigmented cells noted over time. After
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3 days to 6 weeks in culture, the tissues were fixed in 2%
glutaraldehyde. The adult cultures also had thorotrast
added 24 h after the culture began. After fixation, the tissues were post-fixed in Dalton’s chrome osmium fixative
for 1 h and embedded in Epon. When cells were observed
using light and electron microscopy, no difference was
found in the growth between cells taken from dead or living donors, and the RPE cell shapes were found to become
more irregular after 3 days, with no spreading observed,
and attenuation and necrosis after 6 weeks. Different cultures taken from the same patient’s eye showed considerable variation in their proliferation and degeneration,
while the age of the patient did not affect the growth of the
culture. The cultures to which thorotrast had been added
displayed the ability to phagocytose the thorotrast particles (one of the functions of natural RPE cells), which
were engulfed in discrete vesicles after 2 days of incubation. This culture method is recommended for an experimenter attempting to produce a more natural-type RPE
monolayer for drug experimentation.
Aronson134 attempted to identify a consistent procedure
for culturing human RPE cells using choroid fragments as
the seeding vehicle. The choroid fragments were harvested
24 h after delivery from human aborted fetuses 3–4 months
into gestation; they were removed by bisecting the eye
through the optic stalk, pulling off the retina with forceps,
and then peeling off the RPE and choroid as a single sheet.
The sheet was minced with a scalpel and the fragments
plated on tissue culture plastic in 0.08 mL/cm2 of Modified
Eagle’s Medium (MEM) medium (with Flow Auto Pow
No. 11-100 Earle’s salts, 1X BME vitamins, 2 mM glutamine, 0.02% sodium bicarbonate, 50 µg/mL streptomycin, 100 U/mL penicillin, and 10% FBS), and after 1–2
days partially rounded fragments were isolated and placed
on non-tissue-culture plastic Petri dishes. The fragments
were cultured in 0.4 mL/cm2 of medium until they formed
spheres at around 10 days. The spheres were then plated on
tissue culture plastic in 0.08 mL/cm2 of medium and
allowed to grow for 7 days before the tissue fragment was
removed, leaving a new cell line on the plastic. For cell
lines maintained in culture for longer periods (up to 10
months), the medium was changed every 10 days to 2
weeks. RPE cells were easily identifiable by their pigmentation at 3–4 months after initial plating. The researchers
found that RPE sheet separated from the choroid rarely
attached to the plastic and proliferated, while choroidfragment-associated-RPE cells had a higher attachment and
proliferation frequency, often showing fibroblastic outgrowth by day 1. This method involving inclusion of choroidal fragments in the seeding culture is still used by some
researchers,135 and is recommended for researchers looking to start cell lines, although occasionally experimenters
report problems from contaminating choroidal cells.
Oka et al.136 compared the effects of traditional serumsupplemented medium and serum-free defined medium
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(DM) on both human and bovine RPE cells grown in culture. In this section, the human cells will be considered.
The cells were isolated by taking enucleated eyes and rinsing them in 95% ethanol and Sal FM, then removing the
anterior section of the eyeball and vitreous, as previously
described in Mannagh et al.132 The eyecup was rinsed with
warm Sal FM three times and the neural retina removed,
after which each eyecup was filled with 3-5 ml chickentrypsin-hyaluronidase solution (CTH; a mixture of 2%
(v/v) chicken serum, 0.25% (w/v) trypsin, and 0.1% (w/v)
hyaluronidase in calcium- and magnesium-free Puck’s
Saline F) and allowed to incubate for 30 min at 37°C. This
incubation period allowed the RPE cells to disperse into
the CTH in a suspension, which was then removed and
centrifuged in equal volumes of a culture medium (CM)
composed of Dulbecco’s Modified Eagle’s medium
(DMEM)-F12 supplemented with 20% (v/v) FBS. After
centrifuging, the supernatant was removed and the cell pellet re-suspended in CM. The process of dispersal, centrifuging, and re-suspension was repeated several times until
all suspensions were pooled in warm CM. For the final culture, one of the two media were used: either CM or DM
(serum-free DMEM-F12 supplemented with 5.0 µg insulin/
mL, 5.0 µg transferrin/mL, 8.0 ng epidermal growth factor
(EGF)/mL, 0.5 mU follicle stimulating hormone/mL, and
50 ng all-trans retinoic acid/mL). As with most methods
listed, the cells were incubated in a 5% CO2 atmosphere at
37°C, and the medium was changed every 2–3 days. The
cells were cultured on 60 mm culture dishes and passaged
using 0.25% trypsin. The effects of the serum (CM) versus
serum-free medium (DM) were observed and recorded.
Results showed that plating efficiency was consistently
higher in a 1:1 DMEM:F12 mixture than in either DMEM
or F12 alone. It was also observed that the highest plating
efficiency was achieved when the 1:1 mixture was supplemented with 20% FBS (CM, as designated above). Pure
DMEM was found to result in larger, less numerous colonies of RPE cells, while pure F12 resulted in smaller, more
numerous colonies. The CM mixture resulted in a doubling
time of approximately 50 h, which diminished in later passages to 20–25 h and in very late passages increased to 100
h. Fourth passage cells were found in many instances to
stop dividing before confluence. Despite the attempt to
completely eliminate serum from the culturing process
(due to the introduction of hormones and other factors that
may affect cell development),135 serum-containing medium
(CM) was found to be necessary for cell attachment and
spreading although using serum-free medium (DM) after
the initial 24-h plating period in CM resulted in exponential growth. Conversely, cells grown in DM retained epithelioid morphology, while CM-grown cells were larger,
non-epithelioid, and irregular. This procedure is recommended for cultivation of RPE cells for drug experimentation since it produces a viable cell culture that is similar to
natural-type RPE.
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Hunt et al.9 were able to form viable cultures using cells
extracted from eyes donated for corneal transplant, all
from humans aged <40 years. The eyes were first dissected
by removing the anterior portion of the eye globe, vitreous,
lens, and neural retina to expose the RPE (again, the
method outlined by Mannagh et al.132), which they then
rinsed with Hank’s basal salt solution (HBSS). They then
filled the eyecup with 0.5 g trypsin/0.2 g ethylenediaminetetraacetic acid (EDTA)/mL and incubated it at 37°C for
15 min. The detached cells were then aspirated off and
trypsin digestion repeated. All removed cells were then
washed in Ham’s F-10 medium supplemented with 20%
FBS, ITS plus (Collaborative Research), antibiotics, and a
retina extract made by incubating human retina and vitreous in growth medium followed by filtration. The cells
were re-suspended in this same medium, and seeded onto a
variety of surfaces, among which are listed multi-well tissue culture dishes, Millicell (EMD Millipore) or Costar
(Sigma-Aldrich, St. Louis, MO, USA) culture well inserts,
and polycarbonate fibers. All culture surfaces received a
coating to test cell adhesion, with different coatings tested
including laminin, fibronectin, type IV collagen, and
Matrigel (an extracellular matrix (ECM) exudate from a
tumor cell line). The extraction process yielded high concentrations of pigmented cells, with some erythrocytes present in some cases, and it was found that when seeded onto
the plating surfaces the RPE cells adhered rapidly, with
non-adhering cells being removed and the medium changed
after 48 h. The cells were maintained in the same medium
until they grew to confluence, the time required for which
depended on both the seeding concentration and the donor.
Results showed that the laminin-coated substrates (which
were coated in 20 µg/mL laminin in Ham’s F-10 medium)
yielded the greatest cell growth, with cells forming highly
pigmented epithelioid monolayers with intercellular junction complexes as seen in the natural RPE. This was determined to be due to the fact that laminin is a component of
basal RPE lamina and is thought to be concerned in cell
adhesion. The cells were also found to have transferrin
receptors, a component of natural RPE cells. This protocol
is recommended for drug experimentation studies, particularly due to the natural-type intercellular junctions produced by the procedure, which may be useful in experiments
concerned with circumventing the blood–retinal barrier.
Tezel and Del Priore137 attempted to develop a
chemically-defined serum-free medium (CDSFM) to
avoid the problems associated with the use of serum in
RPE culture, similar to Oka et al.136 (see above). They used
cadaver eyes incubated in 25 U/mL dispase for 30 min
after the same dissection used by Mannagh et al.132 The
RPE and choroid were removed together using forceps,
and the loosened RPE sheets pipetted off and placed in
CDSFM, a 1:1 mixture of DMEM:F12 with pyridoxine
HCl, l-glutamine, and 15 mM of HEPES buffer, supplemented with insulin, transferrin, EGF, follicle stimulating
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growth hormone, retinoic acid, sodium selenite, hydrocortisone, triiodothyronine, streptomycin, penicillin,
gentamycin, amphotericin, linoleic acid (10 µg/mL), and
putrescine (0.3 µg/mL) (see publication for further preparation details). The RPE cells were then centrifuged at 1000
r/min for 5 min and the pellet re-suspended in CDSFM,
15% FBS DMEM, or serum-free DMEM, before inoculation on bare or bovine corneal endothelial (BCE)-ECMcoated tissue culture plastic wells. The cells were incubated
in 5% CO2 at 37°C and the respective media of the three
treatments changed every other day. Researchers found the
cells to be confluent after 12 ± 3 days on BCE-ECM and
21 ± 5 days on bare tissue culture plastic. Passaging of
confluent cultures took place by trypsinization and subsequent trypsin deactivation by addition of aprotinin. Results
showed higher seeding efficiency on BCE-ECM than on
bare tissue culture plastic, and that the cells formed fewer
non-hexagonal (fusiform) morphologies. Researchers also
observed higher proliferation rates for the RPE cells in
15% FBS DMEM than in CDSFM (although their respective seeding efficiencies were not significantly different),
demonstrating the benefit of the serum-supplemented
medium (in addition, DMEM without serum was found to
promote lower cell proliferation rates than either of the
other media). Both serum-supplemented DMEM and
CDSFM produced hexagonal epithelioid monolayers,
while serum-free DMEM resulted in large non-mitotic
fusiform cells within a week. This culture technique (using
15% FBS DMEM or CDSFM) is recommended for drug
experimentation, due to the generally epithelioid structure
of the resulting cells and the effects of the various media.
Singh et al.90 cultured human RPE cells to be specifically used for transplantation to treat AMD, experimenting
with two separate substrates (human lens capsule tissue
and hydrogel) to use in the transplants. The lens capsules
were taken from 55-year-old and older patients undergoing
cataract surgery and stored in HBSS at 4°C until used, with
the lens epithelial cells scraped off from the capsule surface using soft-tipped silicon tubing. After cell removal
was confirmed by examination under an inverted phase
microscope, the capsules were laid epithelial-side up in
24-well tissue culture dishes. The hydrogels (manufactured by Organogel Canada L. Tee, Quebec, Canada) were
prepared by free radical co-polymerization of methacrylate
and (meth)acrylamide precursor monomers (ratio 1/0.41
by weight), with ethylene glycol dimethacrylate as a
crosslinking agent. Polymerization occurred between two
pre-cleaned glass microscope slides spaced by a coverslip
for 4 h at 35°C, after which the polymer membranes were
peeled and washed in distilled water until equilibrium
swelling. The swollen gels were cut into circular disks by
a cork borer and then sterilized by autoclaving and stored
in distilled water. The final water content of the hydrogels
was 60%, for a thickness of approximately 25 µm. The
hydrogels were then coated with ECM factors by being
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placed in a well plate with 1 mL of poly-d-lysine (molecular weight (MW): 540,000, 20 µg/L) and HBSS for 5 min,
after which the solution was aspirated off and the hydrogels were incubated overnight at 37°C in 2 mL fibronectin
solution (20 µg/mL) in HBSS. After a day, this solution
was aspirated off as well and the hydrogel allowed to dry
for 30 min under ultraviolet (UV) light (256.7 nm) in a tissue culture hood. The RPE cells themselves were extracted
from eyes of cadavers aged 65–70 years, obtained 8–24 h
after death, using the dissection method found in Mannagh
et al.,132 after which the eyecup was washed with HBSS
(Ca2+ and Mg2+ free) and treated with 0.25% trypsin for 1
h at 37°C. After incubation, the trypsin was aspirated off
and replaced with DMEM with 10% phosphate buffered
solution (PBS) and 100 U/mL penicillin–streptomycin.
The cells were loosened with gentle pipetting and seeded
onto six-well tissue culture dishes, where they were incubated at 37°C in 5% CO2 in DMEM with 10% FBS and
100 U/mL penicillin–streptomycin and the media changed
every 3–4 days. When the cells became confluent, they
were dissociated from the culture plate using 0.05%
trypsin–EDTA, washed, and seeded onto the lens capsules
and hydrogels in 24-well tissue culture dishes at a density
of 6 × 105 cells/mL and incubated in the same conditions
as before.
Results from the study show that cells adhere to and
grow well on both surfaces tested, attaching within 24 h
and forming confluent epithelioid monolayers over a
period of 4–5 days. Viability analysis (Trypan blue exclusion) found 94% ± 0.15% viability on the lens capsules
and 90% ± 0.16% on hydrogel, while immunohistochemical staining showed the presence of ZO-1, a protein associated with tight junctions. This protocol is recommended
for anyone wishing to perform drug treatment tests or RPE
transplantation experiments, based on the highly epithelioid structure of the cell culture.
Tseng et al.103 reported an RPE culture grown from cells
obtained by the evisceration of two living humans during
surgery. In both cases, the choroidal membrane was
removed and stored in F12 medium. In the first case, the
choroid was then cut into small pieces (1 mm2), which were
plated in a 35-mm Falcon dish with 0.5 mL 20% FBS F12
medium. After 1–2 h, an additional 0.5 mL of the same
medium was added to the culture; this action was repeated
with 1 mL of medium after 24 h. Within 7 days of incubation, cells had migrated from the tissue and formed colonies
with heterogeneous morphology, including pigmented epithelioid and fibroblast-like (fusiform) cells. The fibroblastlike cells were capable of propagating and outnumbered the
RPE cells 10 days after culture. In the second case, the choroid was digested in 0.25% trypsin for 30 min at 37°C to
detach the RPE from the stroma. The RPE cells were then
centrifuged and re-suspended in 10% FBS F12 medium.
Pigmented cells attached to the culture dish overnight after
seeding and began spreading in epithelioid morphologies
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after 3 days. The adherent cells began dividing 5 days after
incubation, losing pigmentation with growth and reaching
confluence after 15 days. Subculturing resulted in further
growth and continued epithelioid morphology, while pigmentation continued to decrease. The cells became senescent after 6 passages. In both cases, the cells were grown at
37°C in a 5% CO2 atmosphere, and medium was changed
every 3 days until confluence. Immunocytochemical analysis showed the case 2 cells to have characteristics of epithelial cells, including the presence of cytokeratin. This
protocol is recommended for drug experimentation, due
to the successful growth of RPE cells with a 6-passage
Hayflick limit but with loss of pigmentation.
Akrami et al.123 cultivated human RPE cells in vitro in
order to produce retinal stem cells. The RPE cells were
obtained by opening the eyes (obtained from cadavers 24
h after death), removing the neural retina with forceps,
and then washing the interior of the eyeball globe with
PBS. The RPE layer was pulled out with forceps and cut
into small sections, which were then incubated for 90 min
at 37°C in 2 U/mL dispase. The resulting cell suspension
was centrifuged for 5 min at 300g and 4°C, and the
pelleted cells placed in T25 flasks coated with FBS. The
culture medium used was DMEM:F12 supplemented with
FBS (20% at the beginning of the culture, 10% with all
medium changes afterward), penicillin (120 µg/mL),
streptomycin (220 µg/mL), gentamycin (50 µg/mL), and
amphotericin B (2.5 µg/mL). The medium was changed
twice a week until the cells reached confluence (usually
within 2–3 weeks), after which they were passaged into
new T25 flasks using 3 × 105 cells as the standard concentration per flask. The confluent cells formed an epithelioid
monolayer but showed some loss of pigmentation and
also formed spheroid colonies indicative of the presence
of stem/progenitor cells, with more spheroids forming
from cells harvested from fetal or newborn cadavers. The
spheroids increased in number when confluent cultures
were deprived of FBS and were collected and re-cultured
in 10% FBS DMEM:F12 (either having been dissociated
using trypsin or left intact). The dissociated spheroids
produced new, secondary spheroids, while the untrypsinized primary spheres reattached to the substrate and produced a new monolayer that in turn led to more floating
spheroids. After eight passages, photoreceptors and neurallike cells were detected in the cultures, suggesting they
developed either from retinal stem cells produced by the
colonies or as the result of trans-differentiating or de-differentiating RPE cells. When evaluated immunocytochemically, the cells were found to express RPE-specific
markers RPE 65 (100%) and cytokeratin 8/18 (30%), and
retinal stem/progenitor cell markers Pax-6 (8.6%), Chx10 (11.1%), and Nestin (almost all). This protocol is best
suited for growth of stem cells for the production of selfrenewing RPE tissue, and to trace the origin of the nonRPE tissue.
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Salero et al.35 found human RPE cells to contain stemlike cells, which were found after RPE was isolated from
adult donor eyes (some from cadavers as much as 99 years
old) obtained from eye banks using the method found in
Mannagh et al.132 After dissection, the RPE cells were dissociated by incubation using enzyme-free Hanks’-based
cell dissociation buffer (Gibco, Grand Island, NY, USA) at
37°C. After 10 min, the dissociation buffer was gently
removed and the eyecup filled with 10% FBS DMEM:F12.
RPE sheets of 1 mm2 were removed using gentle scraping
with a double bevel spoon blade (3.0 mm). The sheets were
plated in Matrigel (BD Biosciences, Franklin Lakes, NJ,
USA)-pretreated tissue culture plates, then grown using
“RPE medium” (MEM-α modified medium, 2 mM l-glutamine, penicillin/streptomycin (1:100), 1% Na-pyruvate,
10% FBS) supplemented with THT (taurine, hydrocortisone, and triiodothyronine) and N1. The cells were cultured
in a 37°C 5% CO2 humidified incubator, and the medium
changed every 3 days. The cells grew well, doubling once
every 2 days, and could be passaged at least 6–8 times. The
cultures formed pigmented epithelioid monolayers similar
to those found in the living eye. From some of these monolayers, cells were then isolated, dissociated, and grown
again at clonal density in non-adherent conditions, supplemented with knockout serum replacement (KSR)
medium. This resulted in the development of spheroid colonies, which were found to demonstrate self-renewing
properties when re-cultured. Other cultured epithelioid
monolayers received treatment for 4 weeks with differentiation media resulted in cell markers being detected for
neural, adipocyte, chondrocyte, and osteogenic cells.
Similarity was found between the growth of cells from
young and elderly donors. This protocol would be useful
for growing both natural-type RPE cells (for drug treatment
experiments) and stem cells for AMD treatment.
Maminishkis et al.138 used fetal eyes in an attempt to
establish a reproducible protocol for culturing human fetal
RPE cells to resemble native tissue, with specific requirements including a TER > 100 Ω cm2. The eyes were
obtained from random donors, all used less than 26 h after
enucleation. The eyes were rinsed in 10× diluted antibioticantimycotic solution for 3–5 min, and then rinsed twice
with medium (described below) or PBS to remove the antibiotic. The anterior portion of the eye was removed (as in
Mannagh et al.132) and the posterior portion incubated in
dispase-I solution for 30 min. The posterior poles were then
placed in silicon-padded Petri dishes containing 5% FBS
“RPE medium,” a modified medium, the specifics of which
are outlined in Maminishkis et al.138 (the mixture is similar
to Salero et al.,35 in the previous paragraph). The eyecups
were dissected in quadrants, and the retina and RPE monolayer removed with forceps. The RPE sheets were then
placed in 5% FBS RPE medium, and centrifuged at 100 g,
pipetted gently to separate the cells from the syncytium
(with or without trypsin treatment), and then placed in
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Primaria flasks (Fisher Scientific, Pittsburgh, PA, USA)
with 15% FBS RPE medium. After 1 day, the medium was
replaced with 5% FBS RPE medium, which was changed
every 3–4 days afterward. They displayed confluence and
uniform pigmentation after 3–4 weeks, after which they
were trypsinized in 0.25% trypsin for 10–15 min, resuspended in 15% FBS RPE medium and re-seeded
onto 12-mm 0.4-µm-pore polyester membranes (Fisher
Scientific) in Transwell cell culture inserts (Corning Costar,
Corning, NY, USA) coated in human ECM (10 µg in 150
µL HBSS per well) cured with UV light for 2 h in the hood.
The cells were seeded at a density of 200 × 103 cells/well,
and a similar procedure (excluding the ECM coating) was
used to seed flasks as well. The resulting cells formed confluent monolayers with epithelial morphologies and heavy
pigmentation, with the apical membrane microvilli found
in natural RPE. The cells were experimented with once the
TER exceeded 200 Ω cm2. The final mean TER of 35 monolayers experimented with was found to be 501 ± 138 Ω
cm2. This protocol would be most suitable for drug experimentation and transplantation studies, based on the successful production of epithelioid monolayers with high
TER.
Gamm et al.135 also worked with human fetal RPE cells,
searching for a serum-free system for growing human
RPE. The eyes were taken from fetuses between 10 and 16
weeks of gestation, and shipped overnight at 4°C. The eyes
were dissected in ice-cold DM (dissection medium, consisting of 70% DMEM containing 4.5 g/L d-glucose, and
30% F12 containing l-glutamine, and 1% antibiotic-antimycotic solution; Invitrogen, Carlsbad, CA, USA), removing the anterior section and vitreous as previously detailed.
The eyecups were washed with DM twice and the neural
retina removed by forceps, using irrigation with DM to
loosen retinas that did not detach spontaneously during vitreous removal. The RPE and choroid were then removed
with forceps, and treated in one of the three ways: in the
first treatment, the RPE-choroid sheets were incubated in a
2% dispase-DM solution for 30 min at 37°C and washed in
DM twice, then the choroid peeled off with forceps and the
resulting isolated RPE sheets chopped into 200-µm sections with a McIlwain automated tissue chopper, then
placed in laminin-coated tissue culture plastic in serumfree RPE DM medium (SFRM, DM supplemented with
either 2% B27 (SFRM-B27; Invitrogen) or 1% or 2% N2
(SFRM-N2; Invitrogen)). In the second treatment, the
RPE-choroid sheets were immediately chopped into 200µm sections without dispase digestion, and only those
fragments containing large pieces of RPE were placed in
laminin-coated tissue culture plastic flasks or wells, where
they were also supplemented with one of the two medium
supplements mentioned previously. In the third treatment
(which was devised after observing the reactions of the
cells to the previous two procedures), treatment 2 was
modified in that the chopped RPE-choroid fragments were
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first placed in suspension culture in SFRM-B27, and then
placed in tissue culture dishes. Spherical tissue aggregates
formed within hours and became uniformly pigmented
after 2–4 weeks in culture. After each treatment, the cultures were incubated at 37°C and 5% CO2, and 50%–75%
of the medium was changed every 1–2 days. In all treatments, both cells supplemented with B27 and cells supplemented with N2 showed outgrowth in the first passage
although in all subsequent passages only B27-supplemented
cultures showed substantial continued expansion, and
within 5 days the cells became confluent and adopted a
characteristic RPE morphology. Treatments 1 and 2 were
found to have strong disadvantages (adherence failure and
contaminating choroidal cell colonies, respectively), while
treatment 3 was found to overcome both these disadvantages. This protocol is recommended for drug treatment
experimentation in serum-free medium, due to its successful production of viable RPE cultures.
In 2009, Sonoda et al.7 established a protocol for culturing and differentiating human fetal RPE cells. Their cells
were obtained from preserved tissues taken from 18- to
20-week-old fetuses, shipped within a day to the experimenters. The anterior portion of the eye (referred to as the
cornea–iris complex) was cut off and the vitreous removed.
The posterior eyecup was dissected into four quadrants
using a razor blade before the RPE-choroid layer was
peeled from the retina with forceps (Figure 3). The sheets
were then dipped in a holding buffer and placed in 2% dispase solution for 30 min at 37°C and 5% CO2. After the
30-min period, the sheets were placed back in the holding
buffer to deactivate the dispase, and the RPE peeled off
from the choroid using forceps. The cells were suspended
in 10% FBS RPE medium (RPMI medium) and placed
in a T75 flask. After 24 h, the medium was replaced
with 5% FBS RPE medium to prevent cell overgrowth.
Experimenters observed cell adhesion within those 24 h.
The medium was changed twice a week until confluence.
Within 14 days, the cells formed a dense film, with hexagonal cell morphology which were then passaged and
transplanted onto ECM-coated Transwell membranes.
TER was measured regularly and found to resemble in
vivo values within 4 weeks after passaging, indicating
confluence and tight intercellular junctions. This protocol
was found to produce well-polarized RPE cells in a discrete monolayer, similar to that found in the human eye,
useful for drug treatment and transplant experimentation.

Nonhuman cell sources
While human cells are most desirable for forming anthropogenic RPE monolayers, the ethical issues and limited availability of human donors make culturing RPE cells from
nonhuman animal donors a preferred alternative. RPE
cells have been studied in nonhuman mammals,33,62,139–141
birds,1,142 and amphibians44,115,128 and have been successfully
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harvested and cultured from several species of animals.143
They have been grown in vitro for about as long as people
have been culturing human RPE,144 and many of the protocols established for human cells are also suitable for the cultivation of animal RPE. Oka et al.,136 in addition to culturing
human RPE cells in serum-free DM (see above section), also
worked with bovine cells, with similar results. The dissection
and cell-harvesting process was the same as in human eyes,
as were the culture conditions. Results showed bovine cells
formed confluent monolayers that were grown and passaged
successfully, making this protocol also useful for drug treatment experimentation in nonhuman subjects.
Ho et al.120 cultured cells taken from pig eyes for use in
experiments with RPE transplantation. The eyes were
removed from 6-month-old adult pigs and transported to
the laboratory within 4 h of death in HBSS (Gibco). The
eyeballs were enucleated and sterilized by rapid dipping in
70% ethanol, then air-dried and transferred to MEM PSF
(Eagle’s minimum essential medium (Gibco) with 110 U/
mL penicillin G sodium, 0.1 mg/mL streptomycin sulfate,
and 2.5 µg/mL fungizone (Sigma-Aldrich)), where they
were dissected by removing the anterior part of the eye.
The vitreous and neural retina were removed and the eyecup was washed with 10% FBS MEM PSF with gentle
pipetting. RPE cells were harvested using a fire-polished
pipette and the resulting suspension centrifuged for 5 min
at 800 r/min. The cells were re-suspended in 10% FBS
MEM PSF and placed in 60 mm tissue culture dishes for
culturing, where they were grown to confluence using 20%
FBS MEM PSF. The cultures were incubated at 37°C and
5% CO2 until they reached confluence, being fed 10% FBS
MEM PSF with supplements of 50 mg/mL gentamycin
(Sigma-Aldrich) and 1 ng/mL basic fibroblast growth factor (bFGF, Gibco) twice a week. Cells reached confluence
in 3–4 weeks for primary cultures, after which they were
split 1:5 and passaged into six-well plates or 60 mm culture
dishes. First passage cells grown this way were then harvested using 0.25% edetic acid (Figure 4) in HBSS and
transferred to other culture dishes with high viability
(96.7% ± 2.7% by Trypan blue exclusion). However, it was
found that cell polarization affected reattachment when
replated: cells plated apex down formed aggregates rather
than reattaching in a monolayer, while cells plated base
down reattached and proliferated within 24 h. This protocol
is recommended for experimentation with RPE transplants
that do not use a solid substrate during transplantation.
Singh et al.90 also used pig RPE cells (in addition to
human cells, as detailed in the previous section). The cells
were harvested 2–4 h after death from pig eyes that had
been soaked in sterile prepodyne solution 10 min before
dissection. The cells were obtained by removing the anterior portion of the eye, followed by the vitreous and neural
retina. The eyecup was then washed with HBSS and trypsinized with 0.25% trypsin for an hour at 37°C. The trypsin
was then aspirated off and replaced with 10% FBS DMEM,
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which was then pipetted gently to remove the cells from
the Bruch’s membrane. The RPE cells were seeded onto
six-well tissue culture dishes and incubated at 37°C in 5%
CO2 in 10% FBS DMEM, and the culture changed every
3–4 days. Passaging was performed using 0.05% trypsin–
EDTA, and cells later plated onto human and porcine lens
capsules and hydrogels at 6 × 105 cell/mL seeding densities. RPE cells attached and proliferated well on both lens
capsule (95% ± 0.56% viability) and hydrogel surfaces
(94% ± 0.15% viability), forming confluent monolayers of
polygonal pigmented cells (Figure 5). The pig cells demonstrated the presence of ZO-1 as in the human cells, suggesting tight junctions. This protocol is recommended for
anyone wishing to perform drug treatment tests or RPE
transplantation experiments, based on the highly epithelioid structure of the cell culture.
Hartnett et al.50 grew bovine RPE cells in an experiment
to discover the effects of endothelial cells on the barrier

Figure 4. Porcine RPE cells in suspension after 12 min in
0.25% edetic acid during passaging. Scale bar = 50 µm.120
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function of the RPE. Prior to experiments with endothelial
cells, however, the RPE cells were grown in solo culture to
find the best medium to produce optimum monolayers
with epithelial and barrier characteristics. The fresh bovine
eyes were cleaned of extraneous tissues (including Tenon’s
capsule) and the globes soaked in 20% povidone-iodine
PBS. The eyes were then dissected according to the
Mannagh et al.132 method, and the eyecups filled with
0.125% trypsin warmed to 37°C. After 60 min, the RPE
cells were gently triturated and placed in 10% FBS
DMEM, where they were pelleted. After being re-suspended in medium, the cells were seeded into T25 tissue
culture plastic flasks and grown at 37°C in 5% CO2 using
10% FBS DMEM supplemented with GPS (0.234 mg/m
glutamine, 80 U/mL penicillin, and 80 µg/mL streptomycin C). Experimentation with medium type and its effect
on cell growth followed, using one of three types (all
supplemented with GPS): a hormonally DM (HDM) with
insulin, triiodothyronine, and hydrocortisone), insulin–
transferrin–selenium (ITS DMEM supplemented with 1%
ITS), or calf serum (CS; DMEM with 1% heat-inactivated
CS). The cells were plated at 0.8–2 × 105 cells/cm2 on
0.4-µm-pore inserts of Transwell plates in GPSsupplemented 10% FBS DMEM and grown until confluence (which took 14 days for primary cells and 2–3 days
for passaged cultures). After that, the medium was replaced
with one of the above experimental media (HDM, ITS, or
CS) and grown in a 37°C, 5% CO2 environment. Medium
was changed twice a week. Results of this initial experimentation showed that, while TER rose with time in all
media tested, cultures fed with HDM reached the highest
TER (at 10 days), which remained stable for 20 days. This
led to HDM being selected as the culture medium for the
remaining mixed epithelial-endothelial cell experiments.
This protocol is recommended (using HDM as the culture
medium) for drug treatment testing and barrier property
studies on the RPE.

Figure 5. Cultured porcine RPE cells, grown on a pig lens capsule (top) and a hydrogel (bottom) respectively, as found in Singh
et al.90 Scale bar = 50 µm.
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Israel et al.145 cultured embryonic RPE cells from
domestic chickens by dissecting embryos at stages 29–31
of development. The RPE cell sheets were dissected from
the eyes and dissociated in Coon’s collagenase-trypsinchick serum-EDTA enzyme solution (a mixture of 6 U/mL
collagenase, 0.1% trypsin, 2% chick serum, with 4 mM
EDTA added). The resulting suspension was plated in 3
mL of 5% FBS MEM or F12 medium (supplemented with
0.06 mg/mL penicillin and 0.3 mg/mL glutamine) on 60
mm plastic tissue culture dishes. The cells were incubated
at 37.5°C in 5% CO2 and the medium replaced every 3
days. Cells grown in MEM were shown to form epithelioid
colonies of heavily pigmented cells that grew in mosaiclike monolayers, while cells grown in F12 were large,
fibroblastic, and had little pigmentation (although the centers of the F12 cells become pigmented at 5–6 weeks).
Electronic microscopy revealed further morphological differences between the two cell cultures, with the MEM culture demonstrating the greatest similarity to natural RPE.
Furthermore, the MEM cells were found to be capable of
phagocytizing photoreceptor outer segments and laying
down an ECM similar to Bruch’s membrane. The protocol
that resulted in the first type of cell is recommended for
drug treatment experimentation although its application to
humans may be limited due to the different nature of the
avian RPE cells.

Cell lines
An alternative to using cells from living or dead specimens
is to culture cells that have already been transformed into
cell lines. Immortalized RPE cells are available commercially and often come with a standardized culturing protocol.
One of the most commonly used RPE cell lines is the
ARPE-19 cell line, which was established from cells isolated from the enucleated globes of a 19-year-old male
human donor 2 h after death.111 While ARPE-19 cells have
been used in many studies since the cell line was first established, they show some morphological and developmental
differences from natural-type RPE cells.15,42,78,80,89,146–148 In
general, immortalized cell lines have some physiological
differences from natural cells, and may have different culturing requirements as well; however, variations in culturing
technique are less prevalent than in human- and animalderived cells, due to standardization of culture protocol for
established cell lines. One of the most common problems
with cell-line-derived RPE cells is a lack of pigmentation
and different morphological characteristics than those found
in natural RPE, resulting in a decreased TER when compared to tissue-derived primary cultures;7 the original derivers of the ARPE-19 cell line reported that they were unable
to produce sublines that had a greater TER than the parent
cells.111 However, it is possible to induce immortalized cells
to form pigmented epithelioid monolayers, as shown in the
examples below.

Journal of Tissue Engineering
RPE cells can also form cell lines spontaneously, as
found by Mannagh et al.132 who observed that of the 119
primary RPE cultures they managed to establish from
human donors, 7 spontaneously transformed into cell lines.
The researchers found that the cells became smaller and
more uniform upon transformation, as well as more closely
spaced, and began demonstrating accelerated growth,
approximately halving their generation time. They also
discovered that the transformed cells remained in a monolayer and gradually replaced the remaining primary culture cells. Further study showed that the transformed cells
had changed from diploid to heteroploid, a common indication of transformation of a primary culture into a cell
line. Two of the cell lines established by the study survived
into later years and came from 70- and 21-year-old donors,
respectively. This tendency of RPE cells to spontaneously
form cell lines has been observed in multiple instances,111,121
and the cells produced by such cell lines are recommended
for drug treatment experiments.
Tezcaner et al.149 cultured cell-line-derived RPE cells
with the goal of providing transplants for RPE disorder
patients, using cells from the D407 cell line. The cells were
cultured in 5% FBS DMEM in a 5% CO2 atmosphere at
37°C, and passaged at confluence using 0.05% trypsin–
EDTA. They were then used in experiments to test for the
cells’ ability to reattach to surfaces after dissociation and
proliferate on polyhydroxybutyrate (PHB) films (specifically, PHBV8, either untreated or treated with oxygen
plasma to increase hydrophilicity). During the experiments, the cell culture medium was changed once every
day. PHBV8 films treated with 100 W oxygen plasma for
10 min (the smoothest substrate used in this experiment)
were found to have the greatest success in cell reattachment and growth, forming confluent monolayers within 7
days. The cell seeding densities were also tested, with an
optimal concentration of 25 × 103 cells/cm2 resulting in
49.6% reattachment. Cell seeding densities above and
below this value were found to result in a decrease in cell
reattachment percentages, due to overcrowding or lowered
cell interactions, respectively. This protocol is recommended for experiments with drug treatments and transplantation using cell lines, due to the successful formation
of confluent monolayers.
Tian et al.150 used the ARPE-19 cell line for cultivating
the cells in order to check for transcriptional differences
between the cell line and native RPE from fresh cadaver
eyes. All ARPE-19 cells were seeded at 10,000 cells/cm2 or
100,000 cells/cm2 for 3 days in T75 flasks in 10% FBS
DMEM:F12 and incubated at 37°C in 10% CO2. Confluent
cultures were then grown for 7 days, and then their medium
was replaced with fresh medium containing either serum
(CS treatment) or 1% bovine serum albumin (CSW) for 3
days. Other cells were grown for 2.5 months (no frequency
of medium change given) in 10% FBS DMEM:F12
medium, and then in either serum (DS) or 1% bovine serum
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albumin (DSW) for 3 days. Results showed ARPE-19 cells
grown on plastic to have fewer transcriptional differences
with native RPE than ARPE-19s grown on other surfaces,
and that the two treatments with the fewest transcriptional
differences with native RPE were CSW and DSW.
However, the DS culture showed the greatest morphological similarities to native RPE, displaying a tight mosaiclike monolayer configuration with polygonal, columnar,
highly pigmented cells. Due to these results, the protocol is
recommended for drug treatment experiments, particularly
where transcriptional differences are an issue.
Amemiya et al.122 cultured cells of the ARPE-19 and
H80HrPE-6 (a cell line derived from an 80-year-old human
eye) cell lines in an experiment to evaluate their ability to
trans-differentiate into neurons. Initially, the cells were cultured in 8% heat-inactivated FBS 1% penicillin–streptomycin MEM at 37°C with 5% CO2 (designated the epithelial
culture). The medium was changed every 3 days, and the
cells were found to form a viable epithelioid monolayer
with flat, polygonal morphology. They were able to be passaged using trypsin–EDTA solution and remained healthy
after freezing and thawing. Neither cell line showed pigmentation in short-term culture, although the ARPE-19 cells
developed visible pigmentation after 5 months in culture.
After 2 weeks, when examined immunocytochemically, the
cultured cells showed immunoreactivity for the epithelial
cell marker pancytokeratin, ZO-1, and β-III tubulin (normally only associated with neurons in the retina). After several weeks, the cells were transferred to a neural stem cell
maintenance culture composed of serum-free DMEM:F12
supplemented with 20 ng/mL N2 (Gibco), 20 ng/mL bFGF
(Genzyme, Cambridge, MA, USA), and REC human EGF
(Genzyme) at 37°C with 5% CO2. While maintained in this
medium, the cells were grown on laminin/poly-l-ornithinecoated dishes and the medium was changed every 3 days.
During this time (dubbed the stem-cell-culture period), the
H80HrPE-6 cells became spherical or fusiform after
2 months, and ARPE-19 cells became first elongated
after several days and then spherical or fusiform.
Immunocytochemical analysis showed no pancytokeratin,
ZO-1, or neural markers in the cells. After more than 2
weeks in stem cell culture, the cells were induced to differentiate by being placed in DMEM:F12 with N2, 0.5%
FBS, and 0.5 mM retinoic acid for 10 days, resulting in
their putting out multiple processes into the medium.
Immunocytochemical analysis showed positive results for
β-III tubulin in all cells and for the neural markers MAP5
and NF200 in some cells of both lines. The presence of
mature neural markers and loss of RPE-associated markers
suggest trans-differentiation into neural tissue, while the
higher ratio of MAP5-positive cells in the ARPE-19 cell
line suggests a negative relationship between the age of the
donor and the differentiability of the cells. Due to these
results, this protocol is recommended for stem cell differentiation experiments involving cell lines.

Results and conclusion
The various RPE culture protocols examined in this review
are summarized in the following section. While each
method was successful in producing a culture of viable
RPE cells, differences in resulting cell life, morphology,
function, and structure make different methods preferable
for a researcher desiring a specific type of culture. The
effects of cell source, preparation and extraction method,
culture medium, substrate, incubation, and passaging are
evaluated in section “Conclusion.”

Summary of methods
Each method for culturing RPE cells reviewed is summarized in Table 1 (Supplementary Appendix). Results of
each method are summarized in Table 2 (Supplementary
Appendix).

Cell sources and extraction methods
According to the literature, the use of cells from all
sources listed resulted in viable cultures. For human
cells, both adult and fetal cells grew well, and removal
from eyes was generally accomplished by first peeling
off the RPE and choroid as a single sheet, then dicing/
mincing the tissue with a scalpel, with or without digestion by some digestive enzyme first (trypsin or dispase).
Nonhuman cells, on the other hand, were more often
digested and then dissociated with pipetting, either in the
eyecup or after the RPE-choroid sheet had been removed.
Cultures from cell lines were generally less complicated
to initiate, due to the lack of need for dissection or dissociation, but often led to alterations in cell morphology,
including loss of pigmentation although this may be
overcome. There is no indication that one cell source is
better than another for increasing chances of adhesion
and growth, although with dead specimens, freshness is
highly desired for a viable culture.

Culture media
In general, the medium used was either a form of MEM,
usually supplemented with bovine-derived serum, or a mix
specific to the publication without a standardized name.
Concentrations of supplemental sera varied from 5% to
20%, and other supplements included streptomycin, penicillin, and other antibiotics to help prevent contamination.
Despite the problems associated with using sera as supplements to cell culture media, only four publications
reviewed attempted use of non-serum medium in RPE culture.133,135–137 Of these, the two that compared the nonserum medium to serum-supplemented medium found the
serum-supplemented medium to produce superior results
in terms of cell attachment and proliferation, suggesting
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serum-supplemented medium as the best choice for RPE
culture.

Substrates and incubation
Well plates, culture dishes, and flasks (either T25 or T75)
were the most common growth substrates used. Each demonstrated successful cell attachment and growth. At least
one study149 found the smoothest substrate to be the most
effective in inducing cell attachment. Others90,137 found a
more irregular surface more conducive to cell adhesion
and the development of polygonal, epithelioid cell morphologies. This variation in adhesion potential may be due
to the surfaces resembling Bruch’s membrane (which
natural RPE cells adhere to in vivo) more or less closely.
Incubation was performed almost universally at 37°C and
5% CO2, even for nonhuman cells, the exception being
Israel et al.,145 who incubated avian RPE cells at 37.5°C.
Medium change intervals ranged from 2 to 4 days, with no
difference in cell growth detected between variations.

Passaging
Of the cells successfully passaged, the most commonly
used dissolving agent was trypsin, ranging in concentration (in EDTA) from 0.05% to 0.25%. Most cultures were
passaged at confluence, with successful cell reattachment
and growth on the new surface. Cultures took between 5
and 30 days to reach confluence, depending on the size of
the surface they were grown. Seeding concentrations
ranged from 8.5 × 103 to 6 × 105 cells/mL, with successful
adhesion and cell growth within that range. On average,
non-immortalized cells were able to go through 4–7 passages before growth ceased and cells became senescent,
often altering their morphology at this point.

Conclusion
The science of RPE cell culture, despite having been practiced for over four decades at the time of this writing,
remains an experimental process. Researchers are still
attempting to discover the correct combination of conditions, chemicals, and procedures to produce an artificial
RPE best suited for macular degeneration testing. While
there is still territory left to explore, a few standards have
been established that can be used as guidelines for a cell
scientist wishing to recreate the RPE in vitro.
First, while pigmentation loss and degradation of the
epithelioid formation are common problems for cells harvested from living or cadaverous tissue, both can be minimized with proper medium mixes and plating techniques.
While cells from cell lines often differ from their parent
tissue, some differences (such as pigmentation and cell
shape) can be fixed by manipulating culture conditions.
RPE cells can be grown to form confluent epithelioid
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monolayers on a variety of surfaces and in a variety of
media, although DMEM and its variations were the most
commonly used medium, and serum-based supplements
were found to lead to greater cell attachment and proliferation than non-serum media, although serum may affect cell
morphology.136,137 Cultured RPE cells can be grown to
confluence and successfully passaged, and have been
shown to be able to produce cell lines and retinal stem
cells, and while no cultured RPE monolayer has been successfully transplanted into a human eye yet, as culturing
techniques improve the cells come closer to the state found
in the natural RPE, making such future surgical endeavors
a possibility. Ultimately, the path to devising the ideal culture protocol for approximating the natural human RPE
can only be found through further experimentation. Using
this review as a guide will greatly aid researchers attempting to further research into the retina and AMD treatment.
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Note
*
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as synonymous with fetal calf serum (FCS), despite which
name is used in the source publication.
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Human

Nonhuman Fresh bovine
(bovine)
eyes

Nonhuman 6-month old
(pig)
pigs

Gamm et al.
(2008)

Hartnett et al.
(2003)

Ho et al.
(1997)

Fetal eyes

Aborted
fetuses

Human

Aronson
(1983)

Cadavers

ARPE-19 and
H80HrPE cell
lines

Human

Akrami et al.
(2009)

Laminin-coated tissue
culture plastic

37ºC and 5% CO2,
Initially T25 plastic
medium changed
tissue culture flasks,
twice a week
then porous inserts of
Transwell culture plates
(0.4 µm pore size)

60 mm tissue culture
dishes

SFRM-B27 or
SFRM-N2

Initially 10% FBS GPSsupplemented DMEM;
later, HDM medium
selected as optimal for
producing wild-type
RPE monolayer
10% FBS MEM PSF

Wash eyecup with DM twice, RPE and
choroid removed with forceps, and
either 1) incubated in 2% dispase-DM
solution for 30 min, the RPE peeled
off the choroid and the chopped into
200-um sections, 2) chopped without
dispase digestion, or 3) chopped, then
put in suspension culture of SFRM-B27
37ºC 0.125% trypsin placed in eyecups
for 60 minutes, RPE cells triturated and
placed in 10% FBS DMEM

Eye globe cleaned of
extraneous tissue, then
soaked in 20% povidoneiodine in PBS, anterior
segments removed and
neurosensory retinas
scraped free
Eyecup washed with 10% FBS MEM
Eyes removed and
PSF, cells harvested using pipette
transported to lab within
4 hours of death, carried
in HBSS, eyes enucleated
and sterilized by dipping
in 70% ethanol, air-dried
and transferred to MEM
PSF, dissected by removing
anterior part of eye,
vitreous and retina are
removed

Dissected in ice-cold
DMEM:F12 and 1%
antibiotic-antimycotic
solution, anterior portion
removed, vitreous and
retina removed

37ºC and 5% CO2

First tissue culture
plastic, later non-tissueculture plastic dishes

10% FBS modified
MEM

Bisecting the eye through
optic stalk and removing
the retina with forceps

Peeling off RPE and choroid as single
sheet with forceps, then mincing with
scalpel

(in epithelial culture) Trypsin EDTA
37ºC and 5% CO2,
medium changed
every 3 days
Not passaged
37ºC and 5% CO2,
left to grow for 7
days before forming
cell line
Incubated at 37ºC and Not passaged
5% CO2

Collagen- or laminin/
poly-L-ornithine-coated
dishes

n/a

n/a

Split 1:5 and
passaged into
6-well plates or
60 mm dishes
after 3– 4 weeks

Not passaged

At confluency,
using
3x10^5 cell
concentration

37ºC and 5% CO2,
medium changed
twice a week until
confluency

20% FBS DMEM:F12
(later 10% FBS),
supplemented
with penicillin,
streptomycin,
gentamicin,
amphotericin
8% heat-inactivated
FBS 1% penicillinstreptomycin MEM

FBS-coated T25 flasks

PASSAGE

INCUBATION AND
CULTURE

SUBSTRATE

RPE layer removed with forceps and
diced, then incubated in dispase

CULTURE MEDIUM

Eye opened and neural
retina removed, interior
irrigated with PBS

CELL SOURCE PREPARATION METHOD EXTRACTION METHOD

Amemiya et al. Cell line
(2004)

SOURCE
TYPE

METHOD

Table 1. Summary of RPE culture methods.
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Nonhuman Embryos at
(chicken)
stages 29–31

Human

Human

Human

Nonhuman Cow eyes
(bovine)

Israel et al.
(1980)

Maminishkis
et al. (2007)

Mannagh et al.
(1973)

Oka et al.
(1984)

Oka et al.
(1984)

Rinsed with antibiotic
antimycotic solution for
3–5 minutes, then twice
with medium or PBS,
anterior portion of eye
removed
Anterior portion removed, Eye cup filled with 0.03% pronase
digestion in Ca- and Mg-free salt
eyecup inverted, vitreous
solution, 20-30 minutes
and retina removed

Dissection

CULTURE MEDIUM

Anterior portion removed, Eyecup filled with 3-5 ml CTH for
30 min
vitreous expelled, eyecup
rinsed with warm Sal FM
and retina removed

15% FBS EMEM, with
0.5 U/ml ACTH (to
stimulate pigment
formation)
Two separate media:
each powdered
DMEM and F12, 90%
H20 with sodium
bicarbonate (53.6
mM) and HEPES (15
mM), one with 20%
FBS, one with insulin,
transferrin, EGF, FSH,
and RA
Two separate media:
each powdered
DMEM and F12, 90%
H20 with sodium
bicarbonate (53.6
mM) and HEPES (15
mM), one with 20%
FBS, one with insulin,
transferrin, EGF, FSH,
and RA

Ham’s F-10 medium
supplemented with
20% FBS, ITS plus,
antibiotics, and a
retina extract made
by incubating human
retina and vitreous in
growth medium
RPE removed in sheets and dissociated 5% FBS MEM or F12
in Coon’s collagenase-trypsin-chick
serum-EDTA enzyme solution
Posterior eyecup incubated in dispase-I 5% or 15% FBS
"RPE medium" (see
solution for 30 min, then placed in
publication for details)
medium and dissected in quadrants,
removing retina and RPE with forceps

Anterior portion removed, Eyecup washed with HBSS, then
filled with 0.5 g/0.2 g EDTA/ml and
vitreous expelled, retina
incubated for 15 minutes, dislodged
removed
cells aspirated off, then incubation
repeated

Fresh human
eyes (removed
for corneal
transplants)
Enucleated eyes Anterior portion removed, Eyecup filled with 3-5 ml CTH for
30 min
vitreous expelled, eyecup
rinsed with warm Sal FM
and retina removed

Fetal eyes

Cadaver eyes

Human

Hunt et al.
(1989)

CELL SOURCE PREPARATION METHOD EXTRACTION METHOD

SOURCE
TYPE

METHOD

Table 1. (Continued)

37ºC and 5% CO2

37ºC and 5% CO2,
medium change every
2–3 days

37ºC and 5% CO2,
medium change every
2–3 days

Rose chamber or T25
flask

60 mm culture dishes

60 mm culture dishes

Flasks and porous
polyester membranes
coated with ECM

37.5C and 5% CO2,
medium replaced
every 3 days
37ºC and 5% CO2,
medium changed
every 3-4 days

0.25% trypsin

0.25% trypsin

After 30 days,
with 0.25%
trypsin

At 3–4 weeks
with 0.25%
trypsin

Not passaged

Not passaged
Unspecified
temperature
and atmospheric
conditions, medium
changed first after 48
hours to allow for cell
adhesion

Multi-well tissue
culture dishes, Milicell
or Costar culture
well inserts, or
polycarbonate fibers,
coated with laminin,
fibronectin, type IV
collagen, or Matrigel
60 mm plastic tissue
culture dishes

PASSAGE

INCUBATION AND
CULTURE

SUBSTRATE

(Continued)

Laminin is
component in
natural RPE basal
lamina

SPECIAL NOTES
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SOURCE
TYPE

CELL SOURCE PREPARATION METHOD EXTRACTION METHOD

CULTURE MEDIUM

Human

Tso et al.
(1973)

Eyes eviscerated during
surgery

Anterior portion removed,
vitreous expelled, retina
removed
n/a

Eyes opened in RPMI 1640
Cadavers and
enucleated
eyes from living
melanoma/
retinoblastoma
patients

Living humans

Cell line

Human

ARPE-19 cell
line

Human

Tezel and
Del Priore
(1997)
Tian et al.
(2005)

Tseng et al.
(2004)

Cadaver eyes

Human

Salero et al.
(2012)

Choroidal membrane removed and
stored in F12 medium, then cut into
small pieces
RPE and uvea separated together from
sclera and placed on Millipore filters
choroid-down

Eyecup filled with 25 U/ml dispase for
30 min, RPE and choroid removed
using forceps
n/a

37°C and 5% CO2,
medium changed
every 3 days

Matrigel-pretreated
tissue culture plates

Leighton tube

RPMI 1640

Not passaged

Trypsin,
deactivated with
aprotinin
Cells were grown in
Passaged 6
different conditions
times before
senescence
Not passaged
37ºC and 5% CO2,
medium change every
other day
37ºC and 10% CO2

37ºC and 5% CO2,
medium changed
every 3 days
37ºC and 5% CO2,
medium changes 2
times a week

At confluence
with 0.05%
trypsin-EDTA

37°C and 5% CO2

Thin surface-modified
and unmodified PHBV8
films in 24-well plates
with teflon o-rings, all
sterilized by 20 minutes
of UV
Bare or BCE-ECMcoated tissue culture
plastic wells
T75 flask

35 mm Falcon dish

At confluence

SPECIAL NOTES

37ºC and 5% CO2

Using 0.05%
trypsin-EDTA,
seed at 6 x 10^5
cells/ml

6-8 times

PASSAGE

T75 flasks and ECMcoated Transwell
membranes

Six-well plates, later lens 37ºC and 5% CO2,
capsules and hydrogels media changed every
3– 4 days

INCUBATION AND
CULTURE

SUBSTRATE

20% FBS F12 medium

10% FBS DMEM:F12

CDSFM (see text for
details)

Eyes obtained
Anterior portion removed, RPE isolated and dissociated and plated “RPE medium” (MEMin adherent conditions
α modified medium,
from eye banks eyecup inverted, vitreous
2 mM L-glutamine,
and retina removed
penicillin/streptomycin
(1:100), 1% NaPyruvate, 10% FBS)
10% FBS DMEM with
Singh et al.
Nonhuman Dead pigs
Harvested 2– 4 hours after Anterior portion removed, vitreous
penicillin/streptomycin
(2001)
(pig)
death and soaked in sterile and neural retina removed, eyecup
prepodyne for 10 minutes washed with Hank’s balance salt
solution and trypsinized with 0.25%
trypsin for an hour at 37ºC, cells
removed by pipetting
10% FBS RPE medium
RPE-choroid layer peeled off and
Sonoda et al.
Human
Fetal eyes
Anterior eye portion
(RPMI medium); after
dipped in holding buffer, placed in 2%
(2009)
removed, vitreous
dispase for 30 min, then back in holding 24 hours, 5% FBS RPE
removed, eyecup cut in
medium
buffer; RPE then peeled from choroid
quadrants
with forceps
Tezcaner et al. Cell line
D407 cell line
n/a
n/a
5% FBS DMEM
(2003)

METHOD

Table 1. (Continued)
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Table 2. Summary of culture method results.
METHOD

SOURCE

RESULTS

APPLICATION
RECOMMENDATION

Akrami et al.
(2009)

Human - cadavers

Generating stem cells

Amemiya et al.
(2004)

Cell line - ARPE-19,
H80HrPE

Aronson (1983)

Human - fetuses

Gamm et al.
(2008)

Human - fetuses

Cells formed viable epithelioid monolayer that reached confluence within 2–3 weeks, with
some pigmentation loss. Spheroid colonies pertaining to stem/progenitor cells formed,
forming earlier and in greater numbers from cells from fetal or newborn sources. Spheroid
colonies could be recultured, either as intact spheres or dissociated by trypsin. Cultures
produced photoreceptor and neural-like cells. Cultured cells showed markers for RPE and
retinal stem/progenitor cells.
Cells of both lines formed flat, polygonal epithelioid monolayer without pigmentation. Some
ARPE-19 cells developed visible pigmentation after 5 months in culture. Cells remained healthy
after freezing and thawing. Immunocytochemical analysis showed markers for epithelial cells
and tight junctions. Further experimentation with other media produced transdifferentiated
cells with neural markers.
Choroid-RPE fragments formed spheres and formed cell lines when attached to substrate. RPE
cells on choroidal fragments showed greater attachment and proliferation than mechanicallyseparated RPE cells.
Three different medium treatments were tested, with B27-supplemented medium found to be
superior, producing culture expansion after first passage.

Hartnett et al.
(2003)

Nonhuman – bovine

Use of HDM medium produced viable RPE monolayers similar to wild-type RPE, with higher
TER than those produced by other media tested. High TER remained stable 20 days.

Ho et al. (1997)

Nonhuman porcine

Hunt et al. (1989)

Human - cadavers

Israel et al. (1980)

Nonhuman - avian

Maminishkis et al.
(2007)

Human - fetuses

Mannagh et al.
(1973)

Human - cadavers

Oka et al. (1984)

Human (cadavers)
and non-human
(bovine)

Salero et al. (2012)

Human - cadavers

Singh et al. (2001)

Human (cadavers)
and nonhuman
(porcine)
Human - fetuses

Cells reached confluence in 3– 4 weeks, formed hexagonal monolayer, survived treatment
with edetic acid. Reattachment after edetic acid harvesting treatment was found to be
polarization dependent.
Extraction process yielded high concentration of pigmented cells with some erythrocytes
mixed in. RPE cells adhered rapidly, laminin-coated surfaces yielded highest cell growth and
showed epithelioid pigmented monolayer with intact junction complexes. Cells were found to
have transferrin receptors.
Cells grown in MEM formed monolayers of heavily-pigmented polygonal cells, while cells
grown in F-12 were larger, fibrocytic, and had less pigmentation. MEM cells demonstrated
ability to phagocytize outer segments and lay down ECM.
Confluency and heavy uniform pigmentation after 3-4 weeks. Cells formed epithelioid
monolayers with average TER of 501 ± 138 Ω· cm2, showing tight junctions. Cells had apical
microvilli similar to natural RPE.
Found negative relationship between age of donor and culture viability. Cells formed small
adherent clusters of round, heavily-pigmented cells on floor 48 hours after inoculation. While
cells remained epithelioid with growth, pigmentation decreased, and ACTH was unsuccessful
at stimulating further pigment formation. Cultures spontaneously produced cell lines.
Highest plating efficiency found using CM mixture with FBS. DME resulted in larger, less
numerous colonies than pure F12. CM medium was found to be necessary for cell attachment
and spreading, though serum-free DM increased growth after plating and led to epithelioid
morphology.
Cultures formed pigmented epithelioid monolayers within four weeks and formed stem-like
cells that had markers for neural, adipocyte, chondrocyte, and osteogenic cells. Similar results
found for cells from young and elderly donors.
Human and pig cells on both hydrogels and lens capsules attached and proliferated, forming
polygonal epithelioid monolayers with high viability. Immunohistochemical staining revealed
ZO-1, showing tight junctions.
Cells adhered within first 24 hours and formed a dense monolayer film of hexagonal cells
within 14 days, highly polarized, similar to natural RPE. TER found to resemble in vivo values at
4 weeks after passaging.
Cells formed confluent epithelioid monolayers within 7 days when seeded at 8.5 x10^345x10^3 cells/cm3 on PHBV8 films treated with 100 W oxygen plasma for 10 minutes.
Optimal cell seeding density found to be 25 x 103 cells/cm2 resulting in 49.6% reattachment.
Produced confluent epithelioid cells with some decreased pigmentation and a few mixed
fusiform cells. Highest seeding efficiency with DMEM with serum on BCE-ECM. BCE-ECM led
to fewer fusiform cells. 15% FBS DMEM produced highest proliferation rates. Both 15% FBS
DMEM and CDSFM produced epithelioid monolayers, while serum-free DMEM resulted in
large fusiform cells.
Cells grown for either 7 days or 2.5 months in 10% FBS DMEM:F12 medium, then three
days in 1% bovine serum albumin, showed fewest transcriptional differences with native RPE.
The DS cells showed the greatest similarity to native RPE, forming a pigmented epithelioid
monolayer with tight junctions.
Case 1: Cells migrated from choroid fragment and formed colonies within 7 days, mostly
fibroblast-like cells. Case 2: Pigmented cells began growth 5 days after incubation began, lost
pigmentation, reached confluency in 15 days, showing immunocytochemical indicators of
epithelial cells.
No difference found between cadavers and live patients, cell shapes became more irregular
after 3 days, no spreading, attenuation and necrosis after 6 weeks. Cells retained epithelial
morphology and relatively uniform pigmentation the first 3 days. Thorotrast-supplemented
cultures demonstrated ability to phagocytize thorotrast particles. No variation demonstrated
due age of the patient.

Sonoda et al.
(2009)
Tezcaner et al.
(2003)

Cell line - D407

Tezel and
Del Priore (1997)

Human - cadavers

Tian et al. (2005)

Cell line - ARPE-19

Tseng et al. (2004)

Human - living
evisceration
specimens

Tso et al. (1973)

Human - cadavers
and living patients

Generating stem or
differentiated cells from
cell lines

Starting cell lines

Drug treatment
experimentation in
serum-free medium
Drug treatment
experimentation and
barrier property studies
Transplant experiments

Drug treatment
experimentation

Drug treatment
experimentation
Drug treatment
experimentation and
transplantation studies
RPE culture practice or
cell line production

Drug treatment
experimentation

Drug treatment
experiments and stem
cell generation
Drug treatment and
transplant experiments
Drug treatment and
transplant experiments
Drug treatment and
transplant experiments
Drug treatment
experiments

Drug treatment
experiments

Drug treatment
experiments

Drug treatment
experiments

